Author
Number of items: 22.
2013
  • 12 Minutes and the simple seven. (2013) Michael Kirby
  • 2012
  • Looking back, looking forward : Reflecting on the winter season and the demise of the PCCS. (2012) M. Kirby
  • Long live the difference? : Why women lose out in heart health. (2012) M. Kirby
  • Overactive bladder symptoms and voiding dysfunction in neurologically normal women. (2012) Montserrat Espuna-Pons, Linda Cardozo, Christopher Chapple, Karl-Dietrich Sievert, Phillip van Kerrebroeck and Michael G. Kirby
  • The counterfeit conundrum. (2012) M. G. Kirby and M. Kirby
  • Diagnosis and medical treatment of lower urinary tract symptoms in adult men : Applying specialist guidelines in clinical practice. (2012) M. Oelke, M. Burger, D. Castro-Diaz, E. Chartier-Kastler, M.A.J. Cidre, T. Mcnicholas, P. Radziszewski and M. Kirby
  • Testosterone measurement - Mandatory in ALL men with ED - A response. (2012) Michael Kirby, G. Schnetzler, K.H. Zou and T. Symonds
  • 2011
  • Professional competence of pharmacists in recommending Flomax relief MR (tamsulosin) to men with lower urinary tract symptoms. (2011) M. Kirby, G. Phillips and A. Carr
  • Can simvastatin improve erectile function and quality of life in men with erectile dysfunction? (2011) Daksha Trivedi, Michael Kirby, Felicity Norman, Izabela Przybytniak, Shehzad Ali and D. Wellsted
  • It is astonishing with how little reading a doctor can practise medicine. (2011) M. Kirby
  • A fit body leads to a fit heart and reduced risk of CVD. (2011) Michael Kirby
  • Current benign prostatic hyperplasia treatment : Impact on sexual function and management of related sexual adverse events. (2011) V. G. Mirone, A. Sessa, F. Giuliano, R. Berges, Michael Kirby and I. Moncada
  • Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom : A retrospective database study. (2011) Michael Kirby, G. Schnetzler, K.H. Zou and T. Symonds
  • 2010
  • Pelvic organ prolapse and overactive bladder. (2010) T.A. de Boer, S. Salvatore, L. Cardozo, C. Chapple, C. Kelleher, P. van Kerrebroeck, M. Kirby, H. Koelbl, M. Espuna-Pons, I. Milsom, A. Tubaro, A. Wagg and M. Vierhout
  • Characteristics, Behaviors, and Attitudes of Men Bypassing the Healthcare System When Obtaining Phosphodiesterase Type 5 Inhibitors. (2010) G. Schnetzler, I. Banks, M. Kirby, K.H. Zou and T. Symonds
  • Erectile dysfunction and coronary artery disease prediction : evidence-based guidance and consensus. (2010) G. Jackson, N. Boon, I. Eardley, M. Kirby, J. Dean, G. Hackett, P. Montorsi, F. Montorsi, C. Vlachopoulos, R. Kloner, I. Sharlip and M. Miner
  • Overactive bladder : Is there a link to the metabolic syndrome in men? (2010) M. Kirby, A. Wagg, L. Cardozo, C. Chapple, D. Castro-Diaz, D. de Ridder, M. Espuna-Pons, F. Haab, C. Kelleher, H. Kolbl, I. Milsom, P. van Kerrebroeck, M. Vierhout, S. Salvatore and A. Tubaro
  • 2009
  • Impact on clinical practice of the Joint British Societies' cardiovascular risk assessment tools. (2009) M. Kirby and I. Machen
  • 2008
  • Is duloxetine safe and effective for the treatment of overactive bladder? (2008) Michael Kirby and K.B. Thor
  • A review of adherence to drug therapy in patients with overactive bladder. (2008) R.K. Basra, A. Wagg, C. Chapple, L. Cardozo, D. Castro-Diaz, M.E. Pons, M. Kirby, I. Milsom, M. Vierhout, P. van Kerrebroeck and C. Kelleher
  • 2001
  • Sex inequalities in ischaemic heart disease in primary care - Inhouse clinics may help better to manage patients with heart disease. (2001) T J Ramsbottom, M G Kirby and K Friedli
  • Is erectile dysfunction a marker for cardiovascular disease? (2001) M Kirby, G Jackson, J Betteridge and K Friedli